A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
Part of paid clinical trials in Louisville, Kentucky.
- Sponsor
- Mayo Clinic
- Study ID
- NCT05547698
- Status
- Recruiting
Conditions
- Lung Transplant
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Off-pump lung transplantation — PROCEDUREGeneral anesthesia, intubation with double lumen tube, thoracotomies or clamshell incision, pneumonectomy starting by the less perfused lung in the scan, stump preparation, lung implantation, reperfusion, gradual release of the pulmonary artery clamp, deairing, ventilation of the 1st implanted lung. The process is repeated at the contralateral side. Ventilation of both lungs, chest closure.
- Venoarterial ECMO lung transplantation — PROCEDUREGeneral anesthesia, intubation with double lumen tube, thoracotomies or clamshell incision, heparin, peripheral or central venoarterial ECMO cannulation, first pneumonectomy, stump preparation, lung implantation, reperfusion, release of the pulmonary artery clamp, deairing, ventilation of the 1st implanted lung. The process is repeated at the contralateral side. Ventilation of both lungs, ECMO decannulation, chest closure.
Study Details
The purpose of this research study is to compare the technique of performing bilateral lung transplantation off-pump vs venoarterial ECMO (VA ECMO). The goal of the trial is to determine which technique has lower rates of primary graft dysfunction.
Key Dates
- Start date
- Sep 17, 2022
- Status verified
- Apr 2026
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 228 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Off-Pump Bilateral Lung TransplantationSubjects will receive 'off-pump' technique for lung transplantation as part of standard of care
- Active Comparator: Venoarterial Extra Corporeal Membrane Oxygenation (VA ECMO) Bilateral Lung TransplantationSubjects will receive VA ECMO technique for lung transplantation as part of standard of care
Primary Outcome Measure
Primary Lung Graft Dysfunction (PGD) grade 3 [ Time Frame: 48-72 hours ]
Central Contacts
- Mauricio Villavicencio, MD, MBA507-2557068
- Jackie Reiter507-538-2224
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Of Louisville | Louisville | Kentucky | 40202 | Matthew Fox, Dr. 502-587-4384 |
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | Suraj Yalamuri, MD (SUB_INVESTIGATOR) |
| Baylor College of Medicine | Houston | Texas | 77030 | Gabriel Loor (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Louisville, KY
Related Studies
- Thoracic Specimen RegistryRecruiting · Mayo Clinic · Rochester, Minnesota
- Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant CandidatesRecruiting · Mayo Clinic · Jacksonville, Florida
- Tocilizumab in Lung TransplantationPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Phoenix, Arizona
- Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant RecipientsPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Los Angeles, California